Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

NCT00628810 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: fluorouracil
DRUG: irinotecan hydrochloride
DRUG: leucovorin calcium

Sponsor

Federation Francophone de Cancerologie Digestive